New Republic Capital, LLC

Position in LLY — ELI LILLY & Co

CIK 1989988 CHARLOTTE, NC

Position in LLY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$3,599,489

+$2,088,307 QoQ

Shares Held

3,001

+82.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.19%

of 13F equity value

Holder Rank

#1,976

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New Republic Capital, LLC holds $13,477,197 across 11 Drug Manufacturers - General names. LLY ranks #1 (26.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,001	$3,599,489
2	JNJ	Johnson & Johnson	8,090	$2,054,617
3	AMGN	Amgen Inc	4,966	$1,798,287
4	MRK	Merck & Co., Inc.	11,402	$1,465,157
5	BMY	Bristol Myers Squibb Co	17,698	$1,019,758
6	ABBV	AbbVie Inc.	3,936	$990,455
7	PFE	Pfizer Inc	25,574	$615,821
8	NVS	Novartis AG	3,729	$584,408

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,599,489	3,001	+82.7%	Shares	Sole	2026-07-31
2026-03-31	$1,511,182	1,643	-40.1%	Shares	Sole	2026-05-01
2025-12-31	$2,948,922	2,744	+105.9%	Shares	Sole	2026-02-10
2025-09-30	$1,017,079	1,333	+2.9%	Shares	Sole	2025-10-27
2025-06-30	$1,010,270	1,296	+4.9%	Shares	Sole	2025-08-12
2025-03-31	$1,019,998	1,235	-1.0%	Shares	Sole	2025-05-07
2024-12-31	$963,456	1,248	+5.8%	Shares	Sole	2025-01-29
2024-09-30	$1,045,409	1,180	+1.4%	Shares	Sole	2024-11-04
2024-06-30	$1,053,862	1,164	+2.7%	Shares	Sole	2024-08-14
2024-03-31	$881,428	1,133	+4.7%	Shares	Sole	2024-05-07
2023-12-31	$630,719	1,082	+15.5%	Shares	Sole	2024-02-12
2023-09-30	$503,290	937	+4.5%	Shares	Sole	2023-11-14
2023-06-30	$420,675	897	+6.4%	Shares	Sole	2023-08-14
2023-03-31	$289,503	843	+22.7%	Shares	Sole	2023-09-12
2022-12-31	$251,332	687	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.